Jack & Jill Cough Syrup and Rosiglitazone Maleate

• Generic Name: ipecac
• Dosage Forms: n.a.
• Other Brand Names:

Ipecac is used in the emergency treatment of certain kinds of poisoning. It is used to cause vomiting of the poison.

Only the syrup form of ipecac should be used. A bottle of ipecac labeled as being Ipecac Fluidextract or Ipecac Tincture should not be used. These dosage forms are too strong and may cause serious side effects or death. Only ipecac syrup contains the proper strength of ipecac for treating poisonings.

Ordinarily, this medicine should not be used if strychnine, corrosives such as alkalies (lye) and strong acids, or petroleum distillates such as kerosene, gasoline, coal oil, fuel oil, paint thinner, or cleaning fluid have been swallowed. It may cause seizures, additional injury to the throat, or pneumonia.

Ipecac should not be used to cause vomiting as a means of losing weight. If used regularly for this purpose, serious heart problems or even death may occur.

This medicine in amounts of more than 1 ounce is available only with your doctor's prescription. It is available in ½- and 1-ounce bottles without a prescription. However, before using ipecac syrup, call a poison control center, your doctor, or an emergency room for advice.

• Generic Name: rosiglitazone
• Dosage Forms: n.a.
• Other Brand Names: Avandia

Used as monotherapy or in combination with a sulfonylurea, metformin, or a sulfonylurea and metformin as an adjunct to diet and exercise for the management of type 2 (noninsulin-dependent) diabetes mellitus (NIDDM).

May be added to glyburide/metformin fixed-combination therapy if hyperglycemia is not adequately controlled with the fixed combination.

May be used in combination with repaglinide if hyperglycemia is not adequately controlled with repaglinide monotherapy.

May use fixed combination of rosiglitazone/metformin (Avandamet) when treatment with rosiglitazone and metformin is appropriate.

May use fixed combination of rosiglitazone/glimepiride (Avandaryl) when treatment with rosiglitazone and glimepiride is appropriate.

Metformin is the preferred initial oral antidiabetic agent for patients with type 2 diabetes mellitus. Thiazolidinediones are one of several second-line agents used with other oral antidiabetic agents (e.g., metformin) in patients who are inadequately controlled on their current oral therapy. Because of potential for serious adverse effects, American Diabetes Association (ADA) recommends that clinicians carefully weigh the potential risks and benefits of thiazolidinediones versus other second-line agents (i.e., insulin, sulfonylureas).

Use in combination with insulin not recommended.

Because endogenous insulin is required for activity, not indicated for type 1 diabetes mellitus or diabetic ketoacidosis.